SuperGen

Closed

Dedicated to the development of novel cancer therapies.

Public · Dublin, United States · Founded 1991 · $391.6M raised

Headquarters
Dublin, California
Employees
201–500
Founded
1991
Business Model
B2B
Total Funding
$391.6M
Last Round
$375.0M Corporate RoundOct 2009
Rounds
2
Type
Public

About

SuperGen, Inc. was a Dublin, California-based pharmaceutical company dedicated to the discovery, acquisition, rapid development, and commercialization of cancer therapeutics. Founded in 1991 and listed on Nasdaq (SUPG), the company built a portfolio of oncology drugs including Dacogen (decitabine). In 2011, SuperGen merged with Astex Therapeutics to form Astex Pharmaceuticals, Inc., which was subsequently acquired by Otsuka Pharmaceutical.

Summary

SuperGen is a Biotech company based in Dublin, United States, founded in 1991. It has raised $391.6M in total across 2 rounds, most recently a $375.0M Corporate Round round in Oct 2009. Investors include GlaxoSmithKline.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

Corporate RoundCorporate RoundOct 2009
$375.0M

Sign up to see all 2 rounds

Venture Round through Corporate Round — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

SuperGen on Indexed.vc
<a href="https://indexed.vc/companies/supergen"><img src="https://indexed.vc/api/badge/company/supergen" alt="SuperGen on Indexed.vc" width="260" height="76" /></a>